These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28130841)

  • 1. DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data.
    Goeppert B; Roessler S; Becker N; Zucknick M; Vogel MN; Warth A; Pathil-Warth A; Mehrabi A; Schirmacher P; Mollenhauer J; Renner M
    Histopathology; 2017 Jun; 70(7):1064-1071. PubMed ID: 28130841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.
    Matsushima H; Kuroki T; Kitasato A; Adachi T; Tanaka T; Hirabaru M; Hirayama T; Kuroshima N; Hidaka M; Soyama A; Takatsuki M; Kinoshita N; Sano K; Nishida N; Eguchi S
    Dig Liver Dis; 2015 Dec; 47(12):1067-75. PubMed ID: 26341967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of biliary tract cancers in early-onset patients: A nested multicenter retrospective study of the ACABI GERCOR PRONOBIL cohort.
    Lebeaud A; Antoun L; Paccard JR; Edeline J; Bourien H; Fares N; Tournigand C; Lecomte T; Tougeron D; Hautefeuille V; Viénot A; Henriques J; Williet N; Bachet JB; Smolenschi C; Hollebecque A; Macarulla T; Castet F; Malka D; Neuzillet C; Vernerey D; Boilève A; Turpin A
    Liver Int; 2024 Aug; 44(8):1886-1899. PubMed ID: 38588031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.
    Takemura Y; Ojima H; Oshima G; Shinoda M; Hasegawa Y; Kitago M; Yagi H; Abe Y; Hori S; Fujii-Nishimura Y; Kubota N; Masuda Y; Hibi T; Sakamoto M; Kitagawa Y
    Cancer Med; 2021 Aug; 10(16):5599-5613. PubMed ID: 34245137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis.
    Loeffler MA; Hu J; Kirchner M; Wei X; Xiao Y; Albrecht T; De La Torre C; Sticht C; Banales JM; Vogel MN; Pathil-Warth A; Mehrabi A; Hoffmann K; Rupp C; Köhler B; Springfeld C; Schirmacher P; Ji J; Roessler S; Goeppert B
    J Pathol; 2020 Nov; 252(3):239-251. PubMed ID: 32710569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary intraepithelial neoplasia (BilIN) is frequently found in surgical margins of biliary tract cancer resection specimens but has no clinical implications.
    Matthaei H; Lingohr P; Strässer A; Dietrich D; Rostamzadeh B; Glees S; Roering M; Möhring P; Scheerbaum M; Stoffels B; Kalff JC; Schäfer N; Kristiansen G
    Virchows Arch; 2015 Feb; 466(2):133-41. PubMed ID: 25425476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer.
    Goeppert B; Frauenschuh L; Zucknick M; Stenzinger A; Andrulis M; Klauschen F; Joehrens K; Warth A; Renner M; Mehrabi A; Hafezi M; Thelen A; Schirmacher P; Weichert W
    Br J Cancer; 2013 Nov; 109(10):2665-74. PubMed ID: 24136146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
    Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
    Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive and prognostic values of ERCC1 and XRCC1 in biliary tract cancers.
    Mian M; McNamara MG; Doherty M; Hedley D; Knox JJ; Serra S
    J Clin Pathol; 2016 Aug; 69(8):695-701. PubMed ID: 26763622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
    Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
    Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
    Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
    Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
    Vasuri F; Rocchi L; Degiovanni A; Giunchi F; Brandi G; Treré D; Montanaro L; D'Errico-Grigioni A
    Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
    Zen Y; Sasaki M; Fujii T; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
    J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
    Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
    Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis.
    Charbel A; Tavernar L; Albrecht T; Brinkmann F; Verheij J; Roos E; Vogel MN; Köhler B; Springfeld C; Brobeil A; Schirmacher P; Singer S; Mehrabi A; Roessler S; Goeppert B
    Br J Cancer; 2022 Nov; 127(9):1603-1614. PubMed ID: 36068277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma.
    Chu X; Zhao P; Lv Y; Liu L
    Int J Clin Exp Pathol; 2015; 8(1):328-36. PubMed ID: 25755719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer.
    Nakagawa H; Hayata Y; Yamada T; Kawamura S; Suzuki N; Koike K
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
    Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
    Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.